Great West Life Assurance CO Protagonist Therapeutics, Inc Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 5,213 shares of PTGX stock, worth $231,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,213
Previous 9,083
42.61%
Holding current value
$231,300
Previous $263,000
31.18%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PTGX
# of Institutions
196Shares Held
58.7MCall Options Held
20.8KPut Options Held
109K-
Farallon Capital Management LLC San Francisco, CA5.84MShares$259 Million0.98% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$255 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.29MShares$235 Million3.06% of portfolio
-
Bvf Inc San Francisco, CA3.32MShares$147 Million3.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.24MShares$144 Million0.0% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.18B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...